Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

RE Bachelder, A Crago, J Chung, MA Wendt, LM Shaw… - Cancer research, 2001 - AACR
RE Bachelder, A Crago, J Chung, MA Wendt, LM Shaw, G Robinson, AM Mercurio
Cancer research, 2001AACR
We identify a novel function for the vascular endothelial growth factor (VEGF) in its ability to
stimulate an autocrine signaling pathway in metastatic breast carcinoma cells that is
essential for their survival. Suppression of VEGF expression in metastatic cells in vitro
induced their apoptosis, in addition to inhibiting the constitutively elevated
phosphatidylinositol 3′-kinase activity that is characteristic of these cells and important for
their survival. Hypoxia enhanced the survival of metastatic cells by increasing VEGF …
Abstract
We identify a novel function for the vascular endothelial growth factor (VEGF) in its ability to stimulate an autocrine signaling pathway in metastatic breast carcinoma cells that is essential for their survival. Suppression of VEGF expression in metastatic cells in vitro induced their apoptosis, in addition to inhibiting the constitutively elevated phosphatidylinositol 3′-kinase activity that is characteristic of these cells and important for their survival. Hypoxia enhanced the survival of metastatic cells by increasing VEGF expression. The importance of the VEGF receptor neuropilin was indicated by the ability of a neuropilin-binding VEGF isoform to enhance breast carcinoma survival. Moreover, the expression of neuropilin in neuropilin-deficient breast carcinoma cells protected them from apoptosis. The identification of this VEGF autocrine signaling pathway has important implications for tumor metastasis and therapeutic intervention.
AACR